ClinVar Miner

Submissions for variant NM_000051.3(ATM):c.8307G>A (p.Trp2769Ter) (rs778269655)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000169516 SCV000220986 likely pathogenic Ataxia-telangiectasia syndrome 2014-12-23 criteria provided, single submitter literature only
Invitae RCV000169516 SCV000260922 pathogenic Ataxia-telangiectasia syndrome 2020-10-12 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Trp2769*) in the ATM gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs778269655, ExAC 0.01%). This variant has been observed in an individual affected with ataxia-telangiectasia (PMID: 8845835). ClinVar contains an entry for this variant (Variation ID: 189104). Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). For these reasons, this variant has been classified as Pathogenic.
Color Health, Inc RCV000579481 SCV000682476 pathogenic Hereditary cancer-predisposing syndrome 2020-11-17 criteria provided, single submitter clinical testing This variant changes 1 nucleotide in exon 57 of the ATM gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been reported in individuals affected with breast cancer (PMID: 26786923) and in the compound heterozygous state with a second ATM mutation in individuals affected with ataxia telangiectasia (PMID: 8845835, 22649200). This variant has been identified in 2/251376 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of ATM function is a known mechanism of disease ( Based on the available evidence, this variant is classified as Pathogenic.
Ambry Genetics RCV000579481 SCV001189935 pathogenic Hereditary cancer-predisposing syndrome 2020-10-07 criteria provided, single submitter clinical testing The p.W2769* pathogenic mutation (also known as c.8307G>A), located in coding exon 56 of the ATM gene, results from a G to A substitution at nucleotide position 8307. This changes the amino acid from a tryptophan to a stop codon within coding exon 56. This mutation has been identified in several individuals with Ataxia-telangiectasia (AT) who also carried another mutation in the ATM gene (Gilad S, et al. Hum. Mol. Genet. 1996;5(4):433-9; Jackson TJ et al. Dev. Med. Child Neurol. 2016 07;58:690-7; Ambry internal data). This alteration has also been reported in at least one subject in a study of 13087 breast cancer cases and 5488 control individuals in the UK (Decker B et al. J. Med. Genetic. 2017 11;54:732-741) and was identified in 2/2000 Australian breast or ovarian cancer patients and 0/1997 controls undergoing multigene panel testing for hereditary cancer risk (Thompson ER et al, J. Clin. Oncol. 2016 May;34:1455-9). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
GeneDx RCV001564923 SCV001788165 pathogenic not provided 2020-04-01 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed in individuals with breast, colon, and prostate cancer (Thompson 2016, Decker 2017, Ghazani 2017, Na 2017, AlDubayan 2018, Li 2019); Observed in the compound heterozygous state in individuals with ataxia-telangiectasia (Gilad 1996, Corts 2003, Rbe 2010); Published functional studies demonstrate a damaging effect: absence of protein expression, loss of kinase activity, and increased sensitivity to ionizing radiation (Corts 2003); Not observed at a significant frequency in large population cohorts (Lek 2016); This variant is associated with the following publications: (PMID: 8845835, 25525159, 32338768, 27989354, 29752822, 33436325, 28125075, 28779002, 29478780, 29555025, 26786923, 28716242, 12883528, 20153123, 25133958)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.